AT9 Antibody

What is AT9 Antibody and what is its target in rice research?

AT9 Antibody (CSB-PA187764XA01OFG) is a polyclonal antibody raised in rabbits that specifically targets the AT9 protein (Q9LGQ6) in Oryza sativa subsp. japonica (Rice). This antibody recognizes epitopes from a recombinant Oryza sativa subsp. japonica AT9 protein used as the immunogen. The antibody is designed for research applications focusing on rice protein expression and function, allowing researchers to detect and study this specific protein in various experimental contexts .

The antibody's target is part of the rice proteome involved in cellular functions that can be studied using immunological techniques. Unlike many antibodies in clinical research, plant research antibodies like AT9 are critical tools for understanding fundamental biological processes in crop species.

What validated applications can AT9 Antibody be used for?

AT9 Antibody has been validated for the following research applications:

• ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection of AT9 protein in samples

• Western Blot (WB): For detection of AT9 protein following gel electrophoresis and membrane transfer

These applications allow researchers to detect the presence, abundance, and molecular weight of AT9 protein in experimental samples. The antibody is delivered in liquid form and is purified using antigen affinity methods to ensure specificity for the target protein .

What are the optimal storage and handling conditions for AT9 Antibody?

For maximum stability and effectiveness, AT9 Antibody should be stored according to these guidelines:

How should AT9 Antibody be used in Western blot applications?

When using AT9 Antibody for Western blot analysis, researchers should follow these methodological guidelines:

• Sample preparation: Extract rice protein using appropriate buffers (typically containing protease inhibitors)

• Protein separation: Run samples on SDS-PAGE (typically 10-12% gel)

• Transfer: Transfer proteins to nitrocellulose or PVDF membrane

• Blocking: Block membrane with 5% non-fat milk or BSA in TBST for 1-2 hours at room temperature

• Primary antibody incubation: Dilute AT9 Antibody (optimal dilution should be determined empirically, but typically 1:1000 to 1:5000) in blocking buffer and incubate overnight at 4°C

• Washing: Wash membrane 3-5 times with TBST

• Secondary antibody: Incubate with appropriate anti-rabbit secondary antibody (typically HRP-conjugated)

• Detection: Develop using chemiluminescence or colorimetric detection methods

For optimal results, include positive and negative controls, and validate the observed band size against the expected molecular weight of the AT9 protein.

What strategies can optimize ELISA protocols using AT9 Antibody?

For ELISA applications with AT9 Antibody, consider these methodological approaches:

• Plate coating: Coat with capture antibody or directly with antigen (if performing a direct ELISA)

• Blocking: Use 1-5% BSA or non-fat milk in PBS to reduce non-specific binding

• Antibody dilution: Perform a titration experiment (serial dilutions from 1:100 to 1:10,000) to determine optimal concentration

• Incubation conditions: Incubate antibody solutions at room temperature for 1-2 hours or at 4°C overnight

• Detection system: Use HRP or AP-conjugated secondary antibodies with appropriate substrates

• Quantification: Include a standard curve with known concentrations of recombinant AT9 protein

For sandwich ELISA configurations, consider using AT9 Antibody as either the capture or detection antibody, paired with another antibody recognizing a different epitope on the AT9 protein .

What controls should be included when working with AT9 Antibody?

Proper experimental controls are crucial for reliable results with AT9 Antibody:

Essential controls include:

• Positive control: Sample known to express AT9 protein (e.g., specific rice tissue with confirmed expression)

• Negative control: Sample known not to express AT9 protein or from a knockout/knockdown line

• Technical controls:

  • Secondary antibody only (no primary antibody) to assess non-specific binding

  • Isotype control (irrelevant rabbit polyclonal IgG) to evaluate background

  • Preabsorption control (antibody preincubated with blocking peptide) to confirm specificity

• Loading controls: For Western blots, include detection of housekeeping proteins (e.g., actin, tubulin) to normalize loading

Researchers should also consider developmental and tissue-specific expression patterns of AT9 when selecting appropriate controls .

How does antibody binding kinetics affect AT9 Antibody performance across different assays?

The binding kinetics of AT9 Antibody (association and dissociation rates) significantly impact its performance across different experimental platforms:

Key considerations include:

• Affinity versus avidity: As a polyclonal antibody, AT9 consists of multiple clonal populations recognizing different epitopes, resulting in higher avidity through multiple binding interactions compared to monoclonal antibodies

• Assay-dependent kinetics:

  • In ELISA, high-affinity antibodies typically perform better due to resistance to washing steps

  • In Western blot, antibodies with moderate affinity may perform better as they balance specific binding with reduced background

  • In immunoprecipitation, high-avidity antibodies often perform better to maintain complexes during washing steps

• Temperature effects: Higher temperatures increase dissociation rates, potentially reducing signal in longer protocols

• Buffer composition: Salt concentration, pH, and detergents affect epitope accessibility and binding kinetics

Researchers may need to optimize incubation times and washing stringency based on the specific assay and research question .

What are cross-reactivity considerations when using AT9 Antibody across different rice subspecies?

Cross-reactivity is an important consideration when applying AT9 Antibody to different rice subspecies or related species:

• Subspecies variations: While the antibody is raised against Oryza sativa subsp. japonica AT9 protein, sequence homology should be assessed when working with:

  • Oryza sativa subsp. indica

  • Oryza glaberrima

  • Other Oryza species

• Epitope conservation analysis: Before experimentation, researchers should:

  • Perform sequence alignment of AT9 protein across target species

  • Identify regions of high conservation or variation

  • Predict potential epitopes recognized by the polyclonal antibody

• Experimental validation: Cross-reactivity should be empirically determined through:

  • Western blot with protein extracts from different subspecies

  • ELISA with recombinant proteins from different subspecies

  • Preabsorption controls with heterologous proteins

If cross-reactivity is observed but undesired, affinity purification against the specific target protein may improve specificity .

How can AT9 Antibody be integrated into multi-omics research approaches?

AT9 Antibody can be leveraged in integrative research approaches that combine multiple omics technologies:

• Proteomics integration:

  • Use AT9 Antibody for immunoprecipitation followed by mass spectrometry to identify interaction partners

  • Combine with phospho-specific antibodies to study post-translational modifications

  • Correlate protein levels (detected by AT9 Antibody) with proteome-wide changes

• Transcriptomics correlation:

  • Compare AT9 protein levels (via Western blot or ELISA) with corresponding mRNA expression data

  • Investigate post-transcriptional regulation by examining discrepancies between transcript and protein abundance

• Functional genomics:

  • Apply AT9 Antibody in phenotypic analyses of genetic variants (knockouts, overexpression lines)

  • Correlate protein localization or abundance with genetic markers

  • Use for validation in CRISPR-Cas9 edited rice lines

• Structural biology integration:

  • Combine with protein modeling to correlate epitope accessibility with detection efficiency

  • Use antibody binding data to validate predicted protein structures

This integrated approach allows researchers to build a more comprehensive understanding of AT9 protein function in rice biology .

What are common causes of non-specific binding with AT9 Antibody and how can they be addressed?

Non-specific binding is a frequent challenge when working with polyclonal antibodies like AT9 Antibody. Common causes and solutions include:

For Western blots specifically, optimize SDS-PAGE conditions to ensure good protein separation, and consider using gradient gels to better resolve proteins of similar molecular weights .

How can researchers address weak or inconsistent signals when using AT9 Antibody?

When facing weak or inconsistent signals with AT9 Antibody, consider these methodological approaches:

• Sample preparation optimization:

  • Ensure efficient protein extraction with appropriate buffers

  • Include protease inhibitors to prevent target degradation

  • Optimize protein loading amounts (typically 20-50 μg total protein)

• Antibody optimization:

  • Test different antibody dilutions (consider a dot blot dilution series)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Try different incubation temperatures

• Detection enhancement:

  • Use more sensitive detection reagents (enhanced chemiluminescence)

  • Consider signal amplification methods (biotin-streptavidin systems)

  • Extend exposure times for Western blots

• Buffer optimization:

  • Test different blocking buffers (milk, BSA, commercial alternatives)

  • Adjust salt concentration and pH of wash buffers

  • Consider adding mild detergents to reduce background

• Technical considerations:

  • Ensure antibody hasn't degraded (avoid repeated freeze-thaw cycles)

  • Check secondary antibody compatibility and freshness

  • Validate that the detection system is functioning properly

Each of these variables should be systematically tested and optimized for the specific experimental system .

How can researchers quantitatively analyze data generated using AT9 Antibody?

For quantitative analysis of data generated with AT9 Antibody, follow these methodological guidelines:

• Western blot quantification:

  • Use digital image analysis software (ImageJ, Image Lab, etc.)

  • Perform densitometry on target bands

  • Normalize to loading controls (housekeeping proteins)

  • Include a standard curve with known quantities when possible

  • Use technical and biological replicates (minimum n=3)

• ELISA quantification:

  • Include a standard curve with purified recombinant protein

  • Use 4-parameter logistic regression for curve fitting

  • Ensure samples fall within the linear range of the assay

  • Calculate coefficient of variation between technical replicates (<10% is desirable)

  • Report results as absolute concentrations when standards are available

• Statistical considerations:

  • Apply appropriate statistical tests based on experimental design

  • Account for non-normal distribution of data when necessary

  • Consider multilevel models for experiments with nested factors

  • Report effect sizes along with p-values

• Data presentation:

  • Present raw data alongside normalized results

  • Include representative images of blots/plates

  • Clearly indicate sample sizes and replicates

  • Use appropriate graphs (bar charts for comparisons, box plots for distributions)

These approaches ensure rigorous quantitative analysis essential for reproducible research .

How does the polyclonal nature of AT9 Antibody impact experimental design and interpretation?

The polyclonal nature of AT9 Antibody has important implications for research:

Advantages to consider:

• Recognition of multiple epitopes increases detection sensitivity

• Greater tolerance to minor protein denaturation or modifications

• May detect various protein isoforms or family members

Limitations to address:

• Potential for batch-to-batch variation requiring validation between lots

• Possible cross-reactivity with structurally similar proteins

• May detect degradation products alongside full-length protein

Experimental design considerations:

• Include more comprehensive controls (pre-immune serum, isotype controls)

• Validate specificity through multiple approaches (Western blot, immunoprecipitation)

• Consider epitope mapping to identify primary binding regions

• Maintain consistent antibody lot for longitudinal studies when possible

These factors should inform both experimental design and data interpretation. For highly specific applications, researchers might consider using monoclonal antibodies if available, or affinity-purifying the polyclonal antibody against the recombinant antigen .

What methods can be used to validate AT9 Antibody specificity in research applications?

To ensure experimental rigor, researchers should validate AT9 Antibody specificity through multiple complementary approaches:

• Genetic validation strategies:

  • Test antibody in knockout/knockdown lines

  • Compare expression in tissues with known differential expression

  • Use recombinant expression systems with controlled expression levels

• Biochemical validation methods:

  • Peptide competition assays to block specific binding

  • Immunoprecipitation followed by mass spectrometry identification

  • Sequential immunoprecipitation to confirm single target isolation

  • Parallel detection with alternative antibodies targeting different epitopes

• Analytical validation approaches:

  • Confirm expected molecular weight in Western blot

  • Verify subcellular localization patterns match known distribution

  • Demonstrate signal reduction following target protein depletion

  • Show consistent detection across different experimental conditions

• Advanced validation techniques:

  • Super-resolution microscopy for co-localization studies

  • CRISPR-epitope tagging for antibody binding confirmation

  • Orthogonal detection methods (aptamers, alternative affinity reagents)

These validation steps should be documented and reported in publications to enhance reproducibility and reliability of research findings .

How does antibody stability and shelf-life impact AT9 Antibody performance over time?

Understanding antibody stability factors is crucial for maintaining consistent results:

Key stability considerations include:

• Storage conditions impact:

  • Storage at -80°C provides maximal stability for long-term storage

  • Working aliquots can be maintained at -20°C to minimize freeze-thaw cycles

  • Glycerol content (50% in storage buffer) prevents freezing damage

  • Preservative (0.03% Proclin 300) inhibits microbial contamination

• Degradation mechanisms:

  • Freeze-thaw cycles can cause protein denaturation and aggregation

  • Bacterial contamination may lead to proteolytic degradation

  • Oxidation of amino acid residues can affect binding site conformation

  • Prolonged storage at 4°C may lead to gradual activity loss

• Performance monitoring:

  • Include consistent positive controls across experiments

  • Consider preparing a large batch of positive control lysate/samples

  • Document lot numbers and purchase/thaw dates

  • Perform periodic validation tests on stored antibody

• Extending functionality:

  • Add protein stabilizers (BSA, glycerol) for diluted working solutions

  • Use sterile technique when handling antibody solutions

  • Consider antibody fragmentation (Fab, F(ab')2) for specific applications

  • Aliquot antibody upon receipt to minimize freeze-thaw cycles

Researchers should factor potential activity loss into experimental design, particularly for longitudinal studies spanning months or years .

How can AT9 Antibody be applied in studying stress responses in rice?

AT9 Antibody offers valuable research applications for investigating stress responses in rice:

• Abiotic stress studies:

  • Monitor AT9 protein expression changes under drought, salinity, or temperature stress

  • Compare protein levels across resistant and susceptible rice varieties

  • Correlate protein abundance with physiological stress markers

  • Examine post-translational modifications using phospho-specific antibodies in combination

• Biotic stress applications:

  • Analyze AT9 protein dynamics during pathogen infection

  • Investigate protein localization changes following elicitor treatment

  • Study protein-protein interactions during immune responses

  • Combine with transcriptomic data to examine translational regulation

• Methodological approaches:

  • Time-course experiments to track expression dynamics

  • Subcellular fractionation to monitor protein translocation

  • Co-immunoprecipitation to identify stress-specific interaction partners

  • Quantitative Western blotting or ELISA to measure expression changes

• Integration with molecular breeding:

  • Use as a marker for stress-responsive pathways

  • Correlate protein levels with desirable agronomic traits

  • Screen germplasm collections for variation in expression patterns

  • Validate genetic markers linked to stress tolerance

These applications can provide insights into molecular mechanisms of stress adaptation in rice, potentially contributing to crop improvement strategies .

What considerations are important when using AT9 Antibody in combination with fluorescence microscopy techniques?

When incorporating AT9 Antibody into immunofluorescence microscopy workflows, researchers should consider:

• Sample preparation optimization:

  • Fixation method (paraformaldehyde vs. methanol) affects epitope preservation

  • Embedding media selection impacts section quality and antibody penetration

  • Antigen retrieval methods may be necessary to expose masked epitopes

  • Cell wall permeabilization requires special consideration in plant tissues

• Protocol adjustments:

  • Extended primary antibody incubation (overnight at 4°C) often improves signal

  • Higher antibody concentrations than Western blot (typically 1:50-1:200)

  • Include detergent (0.1-0.3% Triton X-100) to improve penetration

  • Multiple washing steps with agitation to reduce background

• Controls and validation:

  • Include secondary-only controls to assess autofluorescence

  • Use tissue with known expression patterns as positive control

  • Consider pre-adsorption with immunizing peptide as specificity control

  • Compare localization with published or predicted patterns

• Advanced imaging considerations:

  • For co-localization studies, select fluorophores with minimal spectral overlap

  • For super-resolution techniques, select secondary antibodies with appropriate fluorophores

  • For live-cell imaging, consider fluorescent protein fusions as complementary approach

  • For quantitative analysis, include calibration standards

These methodological considerations help ensure reliable and meaningful imaging results when using AT9 Antibody for localization studies .

How does AT9 Antibody performance compare with other antibodies targeting rice proteins?

When evaluating AT9 Antibody against other rice protein antibodies, researchers should consider:

Performance metrics:

Comparative advantages:

• Polyclonal nature provides detection of multiple epitopes

• Affinity purification process enhances specificity

• Storage in glycerol buffer improves stability

Experimental validation:

• Perform side-by-side comparison with alternative antibodies when available

• Consider using multiple antibodies targeting different epitopes for confirmation

• Validate with genetic approaches (knockdown/knockout) when possible

This comparative assessment helps researchers select the most appropriate reagents for their specific research questions and experimental systems .

What experimental design considerations are important when using multiple antibodies in conjunction with AT9 Antibody?

When using AT9 Antibody alongside other antibodies in multiplexed experiments, consider these methodological approaches:

• Antibody compatibility assessment:

  • Host species considerations to avoid cross-reactivity of secondary antibodies

  • Epitope mapping to ensure antibodies don't compete for binding sites

  • Verification that antibodies perform under the same experimental conditions

• Multi-color immunofluorescence design:

  • Select fluorophores with minimal spectral overlap

  • Include single-stain controls for establishing compensation settings

  • Consider sequential rather than simultaneous staining for problematic combinations

  • Validate with co-localization analysis software

• Multiplex Western blotting strategies:

  • Verify proteins can be adequately separated by molecular weight

  • Consider stripping and re-probing versus parallel blots

  • Use differentially labeled secondary antibodies for simultaneous detection

  • Include complete sets of controls for each primary antibody

• Quantitative considerations:

  • Ensure linear range of detection for each antibody

  • Validate that antibodies don't interfere with each other's binding

  • Normalize each target to appropriate loading controls

  • Assess potential differential effects of sample preparation on epitopes

These approaches maximize information yield while minimizing potential artifacts in multiplexed experimental designs .

How should researchers approach the interpretation of contradictory results obtained with AT9 Antibody across different experimental conditions?

When facing contradictory results with AT9 Antibody across different experimental conditions, researchers should implement a systematic troubleshooting approach:

• Methodological validation:

  • Verify antibody activity using consistent positive controls

  • Check for protocol deviations or reagent variations

  • Assess sample preparation consistency and protein integrity

  • Review raw data and image acquisition settings

• Biological hypothesis testing:

  • Consider post-translational modifications affecting epitope recognition

  • Evaluate potential protein isoforms or splice variants

  • Assess developmental or environmental factors affecting expression

  • Investigate potential interacting proteins masking epitopes

• Statistical robustness analysis:

  • Increase sample size to account for biological variability

  • Apply appropriate statistical tests for the specific data type

  • Consider mixed-effects models to account for batch effects

  • Perform power analysis to determine adequate sample size

• Complementary approach integration:

  • Validate with orthogonal methods (qPCR, mass spectrometry)

  • Apply alternative antibodies targeting different epitopes

  • Use genetic approaches (overexpression, knockdown) for validation

  • Consider advanced techniques (proximity ligation assay, CRISPR-epitope tagging)

By systematically addressing these factors, researchers can resolve contradictions and develop a more nuanced understanding of the target protein's biology .

What computational approaches can enhance analysis of data generated with AT9 Antibody?

Advanced computational methods can significantly improve the analysis and interpretation of AT9 Antibody-generated data:

• Image analysis enhancement:

  • Machine learning algorithms for automated Western blot band detection

  • Deconvolution techniques for improved immunofluorescence resolution

  • Batch correction algorithms to normalize across experiments

  • Deep learning approaches for phenotype classification

• Quantitative data modeling:

  • Bayesian hierarchical models to account for technical and biological variability

  • Principal component analysis to identify patterns across multiple experiments

  • Time-series analysis for temporal expression studies

  • Network inference algorithms to contextualize protein interactions

• Integrative multi-omics analysis:

  • Correlation analysis between protein levels and transcriptomic data

  • Pathway enrichment techniques to identify biological processes

  • Causal modeling to infer regulatory relationships

  • Active learning approaches for predicting protein-protein interactions

• Research automation and optimization:

  • Experimental design algorithms to minimize sample size while maintaining power

  • Robotic systems for high-throughput antibody-based assays

  • Automated parameter optimization for immunoassay conditions

  • Quality control metrics for standardized reporting

These computational approaches can extract maximum value from antibody-based experiments while enhancing reproducibility and enabling systems-level insights .

How might emerging antibody engineering techniques improve future versions of AT9 Antibody?

Emerging antibody engineering technologies could enhance next-generation AT9 Antibody research tools:

• Recombinant antibody development:

  • Single-chain variable fragments (scFvs) for improved tissue penetration

  • Bi-specific antibodies for simultaneous targeting of AT9 and interacting proteins

  • Humanized versions for reduced background in human cell systems

  • Site-specific conjugation for precise labeling

• Affinity and specificity enhancements:

  • In vitro affinity maturation through directed evolution

  • Rational design modifications based on structural binding data

  • Deimmunization to reduce non-specific binding

  • Species cross-reactivity engineering for comparative studies

• Functional modifications:

  • pH-sensitive binding domains for specific subcellular targeting

  • Photo-activatable antibodies for spatiotemporal studies

  • Split-antibody complementation systems for protein interaction studies

  • Antibody-enzyme fusions for proximity labeling applications

• Production improvements:

  • Plant-based expression systems for cost-effective production

  • Enhanced stability formulations for extended shelf-life

  • Streamlined purification processes for batch consistency

  • High-throughput screening for optimal clone selection

These advancements could expand the utility of AT9-targeting antibodies in rice research, enabling new experimental approaches and improving data quality and reproducibility .

What are the future prospects for using AT9 Antibody in large-scale phenotypic screening of rice varieties?

AT9 Antibody holds potential for large-scale phenotypic screening applications in rice research:

• High-throughput adaptation strategies:

  • Automated ELISA platforms for processing hundreds of samples

  • Microfluidic immunoassay systems for minimal sample requirements

  • Multiplex bead-based assays for simultaneous protein detection

  • Tissue microarray analysis for rapid screening of multiple varieties

• Field-applicable methodologies:

  • Simplified extraction protocols for field-collected samples

  • Lateral flow immunoassays for point-of-use testing

  • Portable imaging systems for on-site Western blot analysis

  • Lyophilized antibody formulations for field stability

• Integration with breeding programs:

  • Correlation of AT9 protein levels with agronomic traits

  • Selection markers based on optimal protein expression patterns

  • Screening of germplasm collections for natural variation

  • Validation of gene editing outcomes at the protein level

• Data management considerations:

  • Standardized reporting protocols for cross-laboratory comparison

  • Machine learning algorithms for phenotypic classification

  • Database development for protein expression across varieties

  • Integration with genomic and environmental datasets

These applications could accelerate rice improvement programs by establishing connections between molecular phenotypes and agronomic performance across diverse germplasm .